Double Jeopardy: Will the new trials tell us how to manage patients with atrial fibrillation and coronary artery disease?
Int J Cardiol Heart Vasc
.
2019 May 7:23:100369.
doi: 10.1016/j.ijcha.2019.100369.
eCollection 2019 Jun.
Authors
Reza Wakili
1
2
3
,
Lisa Riesinger
1
2
3
,
Anke C Fender
4
,
Dobromir Dobrev
4
Affiliations
1
Clinic for Cardiology and Angiology, West-German Heart and Vascular Center, Faculty of Medicine, University Duisburg-Essen, Germany.
2
Department of Medicine I, University Hospital Munich, Campus Grosshadern, Ludwig-Maximilians-University Munich (LMU Munich), Munich, Germany.
3
German Center for Cardiovascular Research (DZHK e.v.), Partner Site Munich and Munich Heart Alliance (MHA), Munich, Germany.
4
Institute of Pharmacology, West-German Heart and Vascular Center, Faculty of Medicine, University Duisburg-Essen, Germany.
PMID:
31111088
PMCID:
PMC6510696
DOI:
10.1016/j.ijcha.2019.100369
No abstract available